Table of Contents for the Digital Edition of MD Conference Express ESC 2012 MD Conference Express ESC 2012 Contents ESC 2012 Clinical Practice Guidelines TAVI: 10 Years After the First Case PARAMOUNT Trial Results TRILOGY ACS Outcomes Results from the ALTITUDE Trial Results of the WOEST Trial Results from the Aldo-DHF Trial FAME 2 Results Results from the IABP-SHOCK II Trial STEMI Mortality Decreases in France While Some Key Risk Factors Increase Results from the PURE Study PURE: Treatment and Control of Hypertension Genetic Determinants of Variability in Dabigatran Exposure The RE-LY AF Registry TRA 2°P-TIMI 50 Results Rivaroxaban of Benefit in STEMI: ATLAS ACS 2-TIMI 51 Ivabradine Effect on Recurrent Hospitalization for HF CLARIFY: Similar 1-Year Outcomes for Men and Women with Stable CAD HPS2-THRIVE Study Results PRoFESS Study Results Outcomes from the CARDia Trial Hypertension Atrial Fibrillation Heart Failure MD Conference Express ESC 2012 MD Conference Express ESC 2012 - MD Conference Express ESC 2012 (Page 1) MD Conference Express ESC 2012 - MD Conference Express ESC 2012 (Page 2) MD Conference Express ESC 2012 - MD Conference Express ESC 2012 (Page 3) MD Conference Express ESC 2012 - MD Conference Express ESC 2012 (Page 4) MD Conference Express ESC 2012 - Contents (Page 5) MD Conference Express ESC 2012 - ESC 2012 Clinical Practice Guidelines (Page 6) MD Conference Express ESC 2012 - ESC 2012 Clinical Practice Guidelines (Page 7) MD Conference Express ESC 2012 - ESC 2012 Clinical Practice Guidelines (Page 8) MD Conference Express ESC 2012 - TAVI: 10 Years After the First Case (Page 9) MD Conference Express ESC 2012 - TAVI: 10 Years After the First Case (Page 10) MD Conference Express ESC 2012 - PARAMOUNT Trial Results (Page 11) MD Conference Express ESC 2012 - TRILOGY ACS Outcomes (Page 12) MD Conference Express ESC 2012 - Results of the WOEST Trial (Page 13) MD Conference Express ESC 2012 - Results from the Aldo-DHF Trial (Page 14) MD Conference Express ESC 2012 - FAME 2 Results (Page 15) MD Conference Express ESC 2012 - Results from the IABP-SHOCK II Trial (Page 16) MD Conference Express ESC 2012 - STEMI Mortality Decreases in France While Some Key Risk Factors Increase (Page 17) MD Conference Express ESC 2012 - STEMI Mortality Decreases in France While Some Key Risk Factors Increase (Page 18) MD Conference Express ESC 2012 - STEMI Mortality Decreases in France While Some Key Risk Factors Increase (Page 19) MD Conference Express ESC 2012 - PURE: Treatment and Control of Hypertension (Page 20) MD Conference Express ESC 2012 - Genetic Determinants of Variability in Dabigatran Exposure (Page 21) MD Conference Express ESC 2012 - The RE-LY AF Registry (Page 22) MD Conference Express ESC 2012 - TRA 2°P-TIMI 50 Results (Page 23) MD Conference Express ESC 2012 - Rivaroxaban of Benefit in STEMI: ATLAS ACS 2-TIMI 51 (Page 24) MD Conference Express ESC 2012 - Ivabradine Effect on Recurrent Hospitalization for HF (Page 25) MD Conference Express ESC 2012 - CLARIFY: Similar 1-Year Outcomes for Men and Women with Stable CAD (Page 26) MD Conference Express ESC 2012 - HPS2-THRIVE Study Results (Page 27) MD Conference Express ESC 2012 - PRoFESS Study Results (Page 28) MD Conference Express ESC 2012 - Outcomes from the CARDia Trial (Page 29) MD Conference Express ESC 2012 - Hypertension (Page 30) MD Conference Express ESC 2012 - Hypertension (Page 31) MD Conference Express ESC 2012 - Atrial Fibrillation (Page 32) MD Conference Express ESC 2012 - Atrial Fibrillation (Page 33) MD Conference Express ESC 2012 - Heart Failure (Page 34) MD Conference Express ESC 2012 - Heart Failure (Page 35) MD Conference Express ESC 2012 - Heart Failure (Page 36) http://www.nxtbook.com/nxtbooks/md_conference_express/esc2012 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.